CH Biotech R&D Co., Ltd. announced CHB resignation of Brent Randall Smith as Natural-person director, effective March 2, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
90.3 TWD | -0.55% | +4.39% | +12.17% |
08/05 | CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/03 | CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.17% | 29Cr | |
+17.80% | 3.93TCr | |
-.--% | 1.13TCr | |
+1.48% | 798.58Cr | |
+1.79% | 651.26Cr | |
-2.15% | 618.1Cr | |
+36.99% | 542.79Cr | |
-13.59% | 537.34Cr | |
-13.00% | 460.72Cr | |
+4.12% | 388.58Cr |
- Stock Market
- Equities
- 6534 Stock
- News CH Biotech R&D Co., Ltd.
- CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director